News from the life sciences and technology communities north of Boston
|
|
|
|
|
Morphoceuticals is the latest life sciences company to join Emerging Tech Center, a hub of small laboratory suites at 200 Boston Avenue in Medford. Morphoceuticals targets native bioelectrical and biochemical pathways to develop novel therapies that access core aspects of the biological operating system.
|
|
Headquartered in Singapore, Curiox Biosystems is expanding its U.S. presence and will soon move to a larger suite at 400 West Cummings Park, Woburn. Curiox applies its scientific and engineering expertise in surface chemistry and life science instrumentation toward the goal of overcoming critical challenges that slow the pace of life sciences research.
|
|
|
Reuters reports that Ghana has become the first country in the world to approve a new malaria vaccine, from Oxford University, a potential step toward fighting the mosquito-borne disease. Malaria kills more than 600,000 people each year, most of them children in Africa.
According to Oxford scientist Adrian Hill, this is the first time a major vaccine has been approved in an African country ahead of rich nations. "Particularly since COVID, African regulators have been taking a much more proactive stance, they've been saying...we don't want to be last in the queue," he said.
According to Reuters, it is unclear when the vaccine may be rolled out in Ghana as other regulatory bodies, including the World Health Organization (WHO), are still assessing its safety and effectiveness. Read more.
|
|
Yesterday, Sunflower Therapeutics celebrated its 100th day in operation at its lab and office suite at 200 Boston Avenue, Medford. Sunflower is a unique biotech company founded to increase access to vaccines and other new biologic medicines through the development of next-generation manufacturing technologies. The company operates as a public benefit corporation.
The Sunflower team is pictured with CEO and president Kerry R. Love, Ph.D., (top photo, center right) in front of the company's new preserved moss installation by MossWoman horticultural art.
|
|
Michael Schrader, co-founder and CEO of Vaxess Technologies was a presenter at the recent World Vaccine Congress. Michael spoke about how Vaxess’ sustained release patch technology has the potential to fundamentally change how numerous vaccines are distributed and administered, and shared phase 1 clinical results from Vaxess’ patch-based influenza vaccine. Vaxess is headquartered in Cambridge with a GMP manufacturing facility at Cummings Park in Woburn.
|
|
The Fire Awards are BostInno’s premier recognition program, honoring the companies and organizations setting the local innovation economy ablaze. Nominations are now open for the 2023 Fire Awards. The deadline is Sunday, June 18. View details.
Among the 2022 honorees were Cummings leasing clients Seurat Technologies, a 3D printing company based in Wilmington, and SES, a developer of lithium-metal rechargeable batteries for electric vehicles headquartered in Woburn. Read more about the 2022 honorees (subscription required).
|
|
C2i Accelerator (299 Washington Street, Woburn) will host a panel discussion on " Strategies to Advance Startups in Today's Environment." Wednesday, April 19, 4:00 PM. Register.
|
|
The MassBio State of Possible Conference celebrates Massachusetts’ life sciences ecosystem, giving attendees the opportunity to learn from experts, hear from speakers, participate in discussions, and expand their professional networks. Tuesday, April 25, 8:30 AM - 8:00 PM at Royal Sonesta, Cambridge. Register.
The MassBio Align Summit with insights from McKinsey & Company, will bring together innovative startups from the biotech, medtech, and healthtech sectors with potential partners and offer a full day of content, networking, and partnering. Wednesday, April 26, 9:00 AM - 6:00 PM at Royal Sonesta, Cambridge. Cost for attendees is $500. Register.
The MassMEDIC Medtech Impact Symposium & Gala features a half-day Symposium that will bring together a diverse group of stakeholders within our industry to discuss improving standards of care across four distinct conditions: Women’s Health Diagnostics, Orthopedic Joint Replacements, Cardiac Interventions, and Diabetes Treatment. The Gala is MassMEDIC’s annual event celebrating the impact medical technology makes on patients’ lives. Thursday, April 27, 9:00 AM - 11:00 PM at Encore Boston Harbor, Everett. Limited tickets remain available. Register.
|
|
|
|
Save the Date! Join North Shore Technology Council for its spring mixer. The event brings together the NSTC biosciences, technology, and sustainability special interest groups. Thursday, May 18, 5:00 - 7:00 PM, at the new Mission Boathouse in Beverly. The entrance cost is $10 for members and $25 for non-members, and includes two drink tickets and food. Register.
|
|
200 Boston Avenue, Medford
1,700 SF Lab Suites Coming Q3 2023
|
|
New move-in ready lab and office suites will be available Q3 at Cummings' Medford life sciences campus at 200 Boston Avenue. The location offers a collaborative environment with shared conference and huddle rooms.
Lab features include:
|
|
- Steel lab benches with resin countertops and adjustable reagent shelves
- Chemical fume hood with solvent acid storage
- Ceiling-mounted exhaust drops and electrical feeds
- Emergency shower/eyewash station
- Make-up air and exhaust systems
- Lab sinks with point-of-use acid neutralization tanks
|
|
|
|
To learn more about these and other lab suites, contact John Halsey at 781-932-7039 or sales@cummings.com.
|
|
|
|
We welcome your feedback on this newsletter and invite readers to share company news, personnel changes, product launches, funding updates, events, and more. Contact Sue Howland, client engagement manager, at svh@cummings.com to offer your news for upcoming newsletters. We look forward to hearing from you.
|
|
|
|
|
|
|
